Last updated on January 2017

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)

Detailed Study Description

Receive Redovapagon or Placebo for the treatment of nocturia

Clinical Study Identifier: TX147204

Find a site near you

Start Over

Clinical Research of South Florida

370 Minorca Avenue Coral Gables, FL USA
  Connect »